ALB and hydrops fetalis: Similarly, glycated albumin (AUC 0.680 [0.574–0.786], p = 0.002) and esRAGE (AUC 0.631 [0.521–0.741], p = 0.024) were predictive for reinfarction and HF readmission outcomes in the HF cohort, but not in the ACS cohort [48].